Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
- PMID: 8551636
- PMCID: PMC189900
- DOI: 10.1128/JVI.70.2.960-965.1996
Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
Abstract
Rabbits were immunized with recombinant baculovirus-produced virus-like particles (VLPs) of cottontail rabbit papillomavirus (CRPV) to determine whether these antigens could induce long-term protection against experimental challenge with CRPV. Infectious CRPV and human papillomavirus type 11 L1 VLPs were used as positive and negative control immunogens, respectively. Three groups of immunized animals were challenged with 10-fold serial dilutions of infectious CRPV at 2 weeks, 6 months, and 12 months after immunizations. Antibody titers in serum reached 1:10,000 immediately after the final booster immunization and then decayed to 1:150 at 6 months and 1:100 at 12 months in unchallenged rabbits. Serum neutralization titers followed similar kinetics. Papillomas grew on control-immunized rabbits at sites challenged with 10(-1) (100% of sites), 10(-2) (96% of sites), 10(-3) (63% of sites), and 10(-4) (13% of sites) dilutions of virus. At 2 weeks after CRPV L1 VLP immunizations, the rabbits were completely protected against virus challenge. At both 6 and 12 months after CRPV L1 VLP immunizations, strong protection was also observed. In the last two groups, three of seven rabbits were completely protected and only 4 of 14 or 29% of sites challenged with 10(-1 dilution of virus grew papillomas. Papillomas growing at these four sites were also reduced in size (3.5 +/- 0.7 mm) at 50 days postchallenge compared with sites challenged with 10(-1) dilution on control-immunized rabbits (13.2 +/- 4.2 mm). The results demonstrate that strong and long-lasting protection against experimental challenge with papillomaviruses can be achieved with VLP immunogens.
Similar articles
-
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.J Virol. 1995 Jun;69(6):3959-63. doi: 10.1128/JVI.69.6.3959-3963.1995. J Virol. 1995. PMID: 7745754 Free PMC article.
-
Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.J Virol. 2002 Sep;76(17):8900-9. doi: 10.1128/jvi.76.17.8900-8909.2002. J Virol. 2002. PMID: 12163609 Free PMC article.
-
Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.Viral Immunol. 2006 Summer;19(3):492-507. doi: 10.1089/vim.2006.19.492. Viral Immunol. 2006. PMID: 16987067
-
Papillomavirus-like particle vaccines.J Natl Cancer Inst Monogr. 2001;(28):50-4. doi: 10.1093/oxfordjournals.jncimonographs.a024258. J Natl Cancer Inst Monogr. 2001. PMID: 11158207 Review.
-
Papillomavirus-like particles for serology and vaccine development.Intervirology. 1996;39(1-2):54-61. doi: 10.1159/000150475. Intervirology. 1996. PMID: 8957670 Review.
Cited by
-
Vaccines for viral and parasitic diseases produced with baculovirus vectors.Adv Virus Res. 2006;68:193-253. doi: 10.1016/S0065-3527(06)68006-8. Adv Virus Res. 2006. PMID: 16997013 Free PMC article. Review.
-
Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes.Virol J. 2009 Nov 6;6:192. doi: 10.1186/1743-422X-6-192. Virol J. 2009. PMID: 19891790 Free PMC article.
-
Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study.Clin Vaccine Immunol. 2006 Aug;13(8):845-53. doi: 10.1128/CVI.00072-06. Clin Vaccine Immunol. 2006. PMID: 16893983 Free PMC article.
-
The rabbit papillomavirus model: a valuable tool to study viral-host interactions.Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180294. doi: 10.1098/rstb.2018.0294. Philos Trans R Soc Lond B Biol Sci. 2019. PMID: 30955485 Free PMC article. Review.
-
A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.Sci Rep. 2016 Jan 11;6:19042. doi: 10.1038/srep19042. Sci Rep. 2016. PMID: 26750243 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources